Research News

Patients taking dabigatran to prevent stroke should avoid simvastatin and lovastatin, study suggests

BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6275 (Published 22 November 2016) Cite this as: BMJ 2016;355:i6275
  1. Barbara Kermode-Scott
  1. Vancouver

Patients taking the direct acting anticoagulant dabigatran for stroke prevention should not also take the statins simvastatin or lovastatin, researchers have warned.

A study published in the Canadian Medical Association Journal found that these two commonly used statins, when combined with dabigatran etexilate, increased the risk of major haemorrhage in two population based nested case control studies of over 45 000 patients.1

The Canadian Drug Safety and Effectiveness Research Network team identified 397 cases of ischaemic stroke and 1117 cases of major haemorrhage in 45 991 Ontarian patients over age 65 with non-valvular atrial …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe